Telazorlimab
CAS No. 2126777-87-3
Telazorlimab ( —— )
产品货号. M36870 CAS No. 2126777-87-3
Telazorlimab (GBR-830) 是一种针对活化 T 细胞上 OX40 共刺激受体的人源化单克隆抗体。Telazorlimab 可用于自身免疫性疾病的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥4722 | 有现货 |
|
| 10MG | ¥6536 | 有现货 |
|
| 25MG | ¥9179 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Telazorlimab
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Telazorlimab (GBR-830) 是一种针对活化 T 细胞上 OX40 共刺激受体的人源化单克隆抗体。Telazorlimab 可用于自身免疫性疾病的研究。
-
产品描述Telazorlimab (GBR-830) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab can be used for the research of autoimmune diseases.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Immunology/Inflammation related
-
研究领域——
-
适应症——
化学信息
-
CAS Number2126777-87-3
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Guttman-Yassky E, et, al. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Aug;144(2):482-493.e7.?
产品手册
关联产品
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
-
Plasminogen Activato...
Plasminogen Activator Inhibitor 1 (PAI-1)
-
Chromogranin A (324-...
Chromogranin A (324-337), human 是嗜铬粒蛋白 A 的一个肽片段,可从人的回肠类癌肿瘤中分离出来。嗜铬粒蛋白 A 是一种可溶性糖蛋白,与激素和神经肽一起储存在大多数(神经)内分泌细胞和神经元的分泌颗粒中,它也是神经内分泌肿瘤的血浆标志物。
021-51111890
购物车()
sales@molnova.cn

